United Therapeutics | UTHR - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Amarin USD 143.56M 12.5M 2026-06
Ardelyx USD 31.21M 36.79M 2026-03
Baxter International USD 2.15B 133M 2026-06
Bayer EUR 4.29B 1.44B 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Insmed USD 544.76M 37.42M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 20.42B 1.27B 2026-06
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Moderna USD 1.72B 185M 2026-06
Omeros USD 1.9M 2.36M 2025-06
Pfizer USD 976M 727M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
United Therapeutics USD 1.8B 523.5M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06